Workflow
品驰G101脑起搏器
icon
Search documents
中国经济样本观察·企业样本篇|品驰医疗:让中国人用上自己的脑起搏器
Xin Hua She· 2025-07-11 07:04
Core Viewpoint - The emergence of Beijing Pinchi Medical Equipment Co., Ltd. has significantly reduced the cost of implantable brain stimulators in China, benefiting approximately 3 million Parkinson's disease patients and breaking the foreign monopoly in the neuroregulation field [1][8]. Company Development - Pinchi Medical was established in 2008 and began clinical trials for its brain stimulator in 2009, receiving product registration from the National Medical Products Administration in 2013, making China the second country after the U.S. capable of independently developing and producing brain stimulators [5][6][7][8]. - The company has achieved significant milestones, including the development of key technologies and the production of a brain stimulator that holds over 50% market share in China, benefiting thousands of patients [10][11]. Innovation and Technology - Pinchi Medical has transitioned from imitating foreign products to leading innovation in the neuroregulation sector, focusing on quality and independent research in areas such as rechargeable technology and remote control systems [9][10]. - The company has successfully addressed technical challenges, such as the development of a key component that was previously imported, showcasing its commitment to innovation and self-sufficiency [9][11]. Collaboration and Research - The company emphasizes the importance of collaboration between industry, academia, and healthcare, which has accelerated the commercialization of research outcomes and improved product development [11][12]. - Pinchi Medical has established partnerships with institutions like Tsinghua University and Beijing Tiantan Hospital to enhance its research capabilities and address clinical needs [11][12]. Global Expansion - Pinchi Medical has begun to expand its reach internationally, with its vagus nerve stimulator being implanted in patients in Latin America, marking its first overseas operation [13]. - The company aims to integrate traditional Chinese medical practices with neuroregulation technology to create unique medical solutions, while also navigating the challenges of entering competitive global markets [14].